Health
Regeneron suspends Covid-19 antibody trial among sickest patients – UrduPoint News
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow…
Washington, (UrduPoint / Pakistan Point News – 30th Oct, 2020 ) :US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile…
-
Noosa News24 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
Noosa News22 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
General24 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’